Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Enphase Energy Inc. Stock Rallies 6.8%, Outperforms Peers

Enphase Energy Inc. Stock Rallies 6.8%, Outperforms Peers

Dow JonesDow Jones2026/09/08 20:34

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Enphase Energy Inc. rose 6.8% to $38.83 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.6% to 7,673.52 and Dow Jones Industrial Average falling 1.2% to 52,786.07.

This was the stock's third consecutive day of gains.

Enphase Energy Inc. closed 47.3% below its 52-week high of $73.74, which the company achieved on May 29th.

The stock outperformed some of its peers, as Eaton Corp. PLC rose 2.7% to $422.13, TE Connectivity PLC fell 1.8% to $204.99, and Amphenol Corp. Cl A fell 1.23% to $81.76.

Trading volume totaled 6.4 million, compared to the 50-day average of 4.7 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 08, 2026 16:34 ET (20:34 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks